David Roberge - Publications

Affiliations: 
Université de Montréal, Montréal, Canada 

144 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tonneau M, Richard C, Routy B, Campeau MP, Vu T, Filion E, Roberge D, Mathieu D, Doucet R, Beliveau-Nadeau D, Bahig H. A Competing Risk Analysis of the Patterns and Risk Factors of Recurrence in Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109697. PMID 37169303 DOI: 10.1016/j.radonc.2023.109697  0.579
2022 Chartrand G, Emiliani RD, Pawlowski SA, Markel DA, Bahig H, Cengarle-Samak A, Rajakesari S, Lavoie J, Ducharme S, Roberge D. Automated Detection of Brain Metastases on T1-Weighted MRI Using a Convolutional Neural Network: Impact of Volume Aware Loss and Sampling Strategy. Journal of Magnetic Resonance Imaging : Jmri. PMID 35624544 DOI: 10.1002/jmri.28274  0.488
2022 Bahig H, Tonneau M, Blais N, Wong P, Filion E, Campeau MP, Vu T, Al-Saleh A, Tehfé M, Florescu M, Roberge D, Masucci L, Richard C, Menard C, Routy B. tereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC). Clinical and Translational Radiation Oncology. 33: 115-119. PMID 35243022 DOI: 10.1016/j.ctro.2021.12.008  0.577
2022 Le WT, Vorontsov E, Romero FP, Seddik L, Elsharief MM, Nguyen-Tan PF, Roberge D, Bahig H, Kadoury S. Cross-institutional outcome prediction for head and neck cancer patients using self-attention neural networks. Scientific Reports. 12: 3183. PMID 35210482 DOI: 10.1038/s41598-022-07034-5  0.536
2020 Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, ... ... Roberge D, et al. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001255. PMID 32931399 DOI: 10.1200/Jco.20.01255  0.327
2020 Palmer JD, Greenspoon J, Brown PD, Johnson DR, Roberge D. Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis. Neuro-Oncology Practice. 7: 263-267. PMID 32537175 DOI: 10.1093/Nop/Npz047  0.326
2020 Mathieu D, Bedwani S, Mascolo-Fortin J, Côté N, Bernard AA, Roberge D, Yassa M, Bahig H, Vu T. Cardiac Sparing with Personalized Treatment Planning for Early-stage Left Breast Cancer. Cureus. 12: e7247. PMID 32292662 DOI: 10.7759/Cureus.7247  0.591
2020 Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, ... ... Roberge D, et al. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases from 1985 to Today. International Journal of Radiation Oncology, Biology, Physics. PMID 32084525 DOI: 10.1016/J.Ijrobp.2020.01.051  0.306
2020 Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, et al. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902767. PMID 32058845 DOI: 10.1200/Jco.19.02767  0.329
2020 Dautruche A, Filion E, Mathieu D, Bahig H, Roberge D, Lambert L, Vu T, Campeau MP. To biopsy or not to biopsy: A matched cohort analysis of early stage lung cancer treated with stereotactic radiation with or without histologic confirmation. International Journal of Radiation Oncology, Biology, Physics. PMID 32004581 DOI: 10.1016/J.Ijrobp.2020.01.018  0.643
2020 Shi W, Kleinberg L, Jeyapalan SA, Goldlust SA, Nagpal S, Reardon DA, Combs SE, Roberge D, Nishigawa R, Glas M. Phase III TRIDENT trial: Radiation and temozolomide +/- tumor treating fields in newly diagnosed glioblastoma. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps2580  0.302
2020 Zhang S, Lapointe A, Simard M, Filion E, Campeau M, Roberge D, Bouchard H, Carrier J, Blais D, Bedwani S, Bahig H. Evaluation of Radiation Dose Effect on Lung Function Using Iodine Maps Derived from Serial Dual-Energy Computed Tomograms International Journal of Radiation Oncology*Biology*Physics. 108: e366-e367. DOI: 10.1016/j.ijrobp.2020.07.2370  0.564
2019 Rodrigues G, Yartsev S, Roberge D, MacRae R, Roa WH, Panet-Raymond V, Masucci GL, Yaremko BP, D'Souza D, Palma D, Sexton T, Yu E, Pantarotto J, Ahmad B, Fisher B, et al. A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases. Cureus. 11: e6394. PMID 31942264 DOI: 10.7759/Cureus.6394  0.315
2019 Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG, ... ... Roberge D, et al. Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (NCCTG N107C (Alliance)/CEC.3). International Journal of Radiation Oncology, Biology, Physics. PMID 31654784 DOI: 10.1016/J.Ijrobp.2019.10.024  0.317
2019 Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, ... ... Roberge D, et al. Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA). Clinical and Translational Radiation Oncology. 18: 39-45. PMID 31341974 DOI: 10.1016/J.Ctro.2019.06.007  0.323
2019 Hartgerink D, Swinnen A, Roberge D, Nichol A, Zygmanski P, Yin FF, Deblois F, Hurkmans C, Ong CL, Bruynzeel A, Aizer A, Fiveash J, Kirckpatrick J, Guckenberger M, Andratschke N, et al. LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation. Acta Oncologica (Stockholm, Sweden). 1-8. PMID 31257960 DOI: 10.1080/0284186X.2019.1633016  0.357
2019 Harris P, Diouf A, Guilbert F, Ameur F, Letourneau-Guillon L, Ménard C, Masucci L, Bélair M, Roberge D. Diagnostic Reliability of Leptomeningeal Disease Using Magnetic Resonance Imaging. Cureus. 11: e4416. PMID 31245204 DOI: 10.7759/Cureus.4416  0.316
2019 Lenglet A, Campeau MP, Mathieu D, Bahig H, Lambert L, Vu T, Roberge D, Bilodeau L, Filion E. Risk-adapted stereotactic ablative radiotherapy for central and ultra-central lung tumours. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 134: 178-184. PMID 31005213 DOI: 10.1016/J.Radonc.2019.01.035  0.605
2019 Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, ... ... Roberge D, et al. Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress? Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 30885538 DOI: 10.1016/J.Trsl.2019.02.011  0.334
2019 Laurie SA, Banerji S, Blais N, Brule S, Cheema PK, Cheung P, Daaboul N, Hao D, Hirsh V, Juergens R, Laskin J, Leighl N, MacRae R, Nicholas G, Roberge D, et al. Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer. Current Oncology (Toronto, Ont.). 26: e81-e93. PMID 30853813 DOI: 10.3747/Co.26.4116  0.367
2019 Bahig H, Lapointe A, Bedwani S, de Guise J, Lambert L, Filion E, Roberge D, Létourneau-Guillon L, Blais D, Ng SP, Nguyen-Tan PF. Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma. European Journal of Radiology. 110: 1-6. PMID 30599844 DOI: 10.1016/J.Ejrad.2018.11.005  0.674
2019 Mathieu D, Daoust VC, Campeau MP, Filion É, Bilodeau L, Bahig H, Roberge D, Lenglet A, Bedwani S. Central3D: A Computer Tool to Help Clinicians Differentiate Central and Peripheral Lung Tumors. Practical Radiation Oncology. 9: e98-e102. PMID 30031220 DOI: 10.1016/J.Prro.2018.07.002  0.604
2019 Wefel JS, Pugh S, Gondi V, Brown PD, Tome W, Armstrong TS, Bruner D, Bovi J, Robinson C, Khuntia D, Grosshans D, Konski A, Roberge D, Kundapur V, Devisetty K, et al. NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM) Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_642  0.303
2019 Nait Ajjou M, Assad A, Letourneau Guillon L, Belanger K, Lemieux Blanchard E, Lemieux B, Bahary J, G Masucci L, Roberge D, Menard C, Lambert C, Moumdjian R, Berthelet F, Ben-Abdallah M, De Guise J, et al. HOUT-28. FIRST-LINE TEMOZOLOMIDE VS PCV FOR LOW GRADE GLIOMAS: A 11 YEARS REAL-WORLD DATA FROM CHUM, UNIVERSITY CENTER Neuro-Oncology. 21: vi118-vi118. DOI: 10.1093/Neuonc/Noz175.493  0.538
2019 Zeidan E, Assad A, Letourneau Guillon L, Belanger K, Lemieux Blanchard E, Lemieux B, Bahary J, Roberge D, G Masucci L, Menard C, Lambert C, Moumdjian R, Berthelet F, Ben-Abdallah M, De Guise J, et al. HOUT-14. PROGNOSTIC IMPACT OF FIRST PSEUDOPROGRESSION ON MRI IN GLIOBLASTOMA, AN 11 YEARS EXPERIENCE FROM A CANADIAN UNIVERSITY CENTER Neuro-Oncology. 21: vi114-vi115. DOI: 10.1093/Neuonc/Noz175.479  0.53
2018 Roberge D, Brown PD, Whitton A, O'Callaghan C, Leis A, Greenspoon J, Smith GL, Hu JJ, Nichol A, Winch C, Chan MD. The Future Is Now-Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018! Frontiers in Oncology. 8: 380. PMID 30271753 DOI: 10.3389/Fonc.2018.00380  0.348
2018 Bahig H, de Guise J, Vu T, Blais D, Chartrand-Lefebvre C, Nguyen NT, Lavertu S, Guay JP, Bedwani S, Roberge D. In a Heartbeat: An Assessment of Dynamic Dose Variation to Cardiac Structures Using Dual Source Computed Tomography. International Journal of Radiation Oncology, Biology, Physics. PMID 29559290 DOI: 10.1016/J.Ijrobp.2018.01.049  0.652
2018 Jumeau R, Delouya G, Roberge D, Donath D, Béliveau-Nadeau D, Campeau MP. Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 50: 396-400. PMID 29326012 DOI: 10.1016/J.Dld.2017.12.013  0.344
2018 Alameddine R, Wong P, Masucci L, Roberge D, Menard C, Routy B, Tehfe M, Blais N, Florescu M. MA08.11 Early Safety Data of a Phase I/II Combining Nivolumab and Stereotactic Brain Radiosurgery for Treatment of Brain Metastases in Patients with NSCLC Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.384  0.303
2018 Mathieu D, Campeau M, Bahig H, Vu T, Lambert L, Bedwani S, Lavoie C, Roberge D, Gorgos A, Filion É. Prospective Evaluation of Quality of Life and Pulmonary Function in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Robotic Stereotactic Body Radiation Therapy: 5-year Results International Journal of Radiation Oncology*Biology*Physics. 102: e741. DOI: 10.1016/J.Ijrobp.2018.07.1980  0.626
2018 Dautruche A, Filion E, Mathieu D, Roberge D, Lambert L, Vu T, Campeau MP. Outcomes of Stereotactic Ablative Radiation Therapy for Presumed Early-Stage Lung Cancer: Three-Year Results in a 119 Patient Cohort International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1834  0.414
2018 Mathieu D, Bilodeau L, Cousineau Daoust V, Filion É, Bedwani S, Lenglet A, Roberge D, Bahig H, Vu T, Côté N, Campeau M. Dosimetric Impacts of Variations in Organ at Risks Delineation during Lung Stereotactic Ablative Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: e546. DOI: 10.1016/J.Ijrobp.2018.07.1524  0.617
2018 Wong P, Lambert L, Thanomsack P, Coulombe G, Lambert C, Charpentier AM, Barkati M, Fortin I, Roberge D. Quality of Life: A Prospective Randomized Trial of Palliative Volumetric Arc Therapy (VMAT) Versus Conformal Radiation Therapy (CRT) International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.06.075  0.323
2017 Bahig H, Campeau MP, Lapointe A, Bedwani S, Roberge D, de Guise J, Blais D, Vu T, Lambert L, Chartrand-Lefebvre C, Lord M, Filion E. Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning. International Journal of Radiation Oncology, Biology, Physics. 99: 334-343. PMID 28871983 DOI: 10.1016/J.Ijrobp.2017.05.051  0.723
2017 Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG, Farace E, ... ... Roberge D, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. The Lancet. Oncology. PMID 28687377 DOI: 10.1016/S1470-2045(17)30441-2  0.306
2017 Jumeau R, Filion É, Bahig H, Vu T, Lambert L, Roberge D, Doucet R, Campeau MP. A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC. The British Journal of Radiology. 20170196. PMID 28590814 DOI: 10.1259/Bjr.20170196  0.581
2017 Bahig H, Nguyen-Tan PF, Filion É, Roberge D, Thanomsack P, de Guise J, Blais D, Doucet R, Létourneau-Guillon L, Lambert L. Larynx motion considerations in partial larynx volumetric modulated arc therapy for early glottic cancer. Journal of Medical Imaging and Radiation Oncology. PMID 28557310 DOI: 10.1111/1754-9485.12612  0.67
2017 Iskanderani O, Roberge D, Coulombe G. Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature. Cureus. 9: e1115. PMID 28451474 DOI: 10.7759/Cureus.1115  0.322
2017 Mathieu D, Campeau MP, Bedwani S, Roberge D, Doucet R, Zerouali K, Bahig H, Vu T, Lambert L, Masucci L, Filion E. The impacts of mid-treatment CBCT-guided patient repositioning on target coverage during lung VMAT. Journal of Medical Imaging and Radiation Oncology. PMID 28168813 DOI: 10.1111/1754-9485.12591  0.617
2017 Bahig H, Lapointe A, Bedwani S, Lambert L, Filion E, Roberge D, de Guise J, Letourneau-Guillon L, Nguyen-Tan P. Dual-Energy Computed Tomography for Prediction of Local Recurrence in Larynx and Hypopharynx Squamous Cell Carcinoma International Journal of Radiation Oncology*Biology*Physics. 99: S195. DOI: 10.1016/J.Ijrobp.2017.06.485  0.656
2017 Mathieu D, Daoust VC, Bilodeau L, Bedwani S, Filion E, Lenglet A, Bahig H, Vu T, Roberge D, Campeau M. Central3D: A Clinical Tool for Robust Characterization of Centrally Located Non–small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E478-E479. DOI: 10.1016/J.Ijrobp.2017.06.1748  0.582
2017 Lenglet A, Mathieu D, Campeau M, Bahig H, Vu T, Roberge D, Bilodeau L, Filion E. Risk-Adapted Lung SBRT for Central and Ultra-Central Tumors International Journal of Radiation Oncology*Biology*Physics. 99: E473-E474. DOI: 10.1016/J.Ijrobp.2017.06.1735  0.576
2016 Hijazi H, Campeau MP, Roberge D, Donath D, Lapointe R, Vandenbroucke-Menu F, Taussky D, Boudam K, Chan G, Bujold A, Delouya G. Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience. Cureus. 8: e935. PMID 28123916 DOI: 10.7759/Cureus.935  0.312
2016 Jumeau R, Bahig H, Filion É, Campeau MP, Lambert L, Roberge D, Gorgos AB, Vu T. Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma. Cureus. 8: e901. PMID 28070470 DOI: 10.7759/Cureus.901  0.642
2016 Lapointe A, Bahig H, Zerouali K, Blais D, De Guise J, Carrier J, Filion E, Roberge D, Bedwani S. SU-F-J-91: Sparing Lung Function in Treatment Planning Using Dual Energy Tomography. Medical Physics. 43: 3427. PMID 28046834 DOI: 10.1118/1.4955999  0.598
2016 Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, ... ... Roberge D, et al. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). Jama Oncology. PMID 27892978 DOI: 10.1001/Jamaoncol.2016.3834  0.38
2016 Bahig H, Simard D, Létourneau L, Wong P, Roberge D, Filion E, Donath D, Sahgal A, Masucci L. A Study of Pseudoprogression After Spine Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: 848-856. PMID 27788956 DOI: 10.1016/J.Ijrobp.2016.07.034  0.602
2016 Bahig H, Campeau MP, Roberge D, Lapointe A, Bedwani S, Vu T, Lambert L, de Guise J, Chartrand-Lefebvre C, Blais D, Lord M, Del Vecchio P, Filion E. Phase 1-2 Study on the Role of Dual-Energy Computed Tomography (DECT) for Assessment of Pulmonary Function in Radiation Therapy Planning. International Journal of Radiation Oncology, Biology, Physics. 96: S45. PMID 27675933 DOI: 10.1016/J.Ijrobp.2016.06.120  0.694
2016 Mathieu D, Campeau MP, Doucet R, Zerouali K, Bedwani S, Bahig H, Lambert L, Vu TT, Roberge D, Filion EJ. Does Midtreatment Cone Beam Computed Tomography-Guided Patient Repositioning During Lung Volumetric Modulated Arc Therapy Impact Target Coverage? International Journal of Radiation Oncology, Biology, Physics. 96: E652. PMID 27675270 DOI: 10.1016/J.Ijrobp.2016.06.2262  0.603
2016 Jumeau R, Filion E, Bahig H, Vu T, Lambert L, Roberge D, Doucet R, Campeau MP. Limiting Chest Wall Toxicity by Adapting the Dose Schedule and Dose Constraints in Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E457. PMID 27674741 DOI: 10.1016/J.Ijrobp.2016.06.1778  0.624
2016 Jumeau R, Bahig H, Filion EJ, Campeau MP, Lambert L, Roberge D, Gorgos AB, Vu T. Is It Time for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy of Early-Stage Non-Small Cell Lung Cancer? International Journal of Radiation Oncology, Biology, Physics. 96: E455. PMID 27674738 DOI: 10.1016/J.Ijrobp.2016.06.1772  0.634
2016 Bahig H, de Guise J, Vu T, Chartrand-Lefebvre C, Blais D, Lebeau M, Nguyen NT, Roberge D. Analysis of Pulmonary Vein Antrums Motion with Cardiac Contraction Using Dual-Source Computed Tomography. CurēUs. 8: e712. PMID 27610284 DOI: 10.7759/cureus.712  0.619
2016 Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, ... ... Roberge D, et al. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. International Journal of Radiation Oncology, Biology, Physics. 96: 406-413. PMID 27598807 DOI: 10.1016/J.Ijrobp.2016.06.006  0.335
2016 Bahig H, Petrogiannis-Haliotis T, Pehr KL, Roberge D. Primary Cutaneous B-Cell Lymphoma in Young Monozygotic Twins: A Case Report. Journal of Cutaneous Medicine and Surgery. PMID 27358311 DOI: 10.1177/1203475416658000  0.518
2016 Béliveau-Nadeau D, Callejo S, Roberge D. Technique for Robotic Stereotactic Irradiation of Choroidal Melanoma. Cureus. 8: e582. PMID 27226942 DOI: 10.7759/Cureus.582  0.314
2016 Bauman G, Yartsev S, Roberge D, MacRae R, Roa W, Panet-Raymond V, Masucci L, Yaremko B, D'Souza D, Palma D, Sexton T, Yu E, Pantarotto JR, Ahmad B, Fisher B, et al. Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases. Journal of Neuro-Oncology. PMID 27084705 DOI: 10.1007/S11060-016-2128-7  0.353
2016 Bahig H, Filion E, Vu T, Chalaoui J, Lambert L, Roberge D, Gagnon M, Fortin B, Béliveau-Nadeau D, Mathieu D, Campeau MP. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease. Practical Radiation Oncology. PMID 27068780 DOI: 10.1016/J.Prro.2016.01.009  0.639
2016 Sperduto P, Yang TJ, Beal K, Pan H, Brown P, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle JM, Kirkpatrick J, Mak K, Shih H, ... ... Roberge D, et al. BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA) Neuro-Oncology. 18: vi27-vi27. DOI: 10.1093/Neuonc/Now212.106  0.372
2016 Jumeau R, Bahig H, Filion E, Campeau M, Lambert L, Roberge D, Gorgos A, Vu T. 161: Is it Time for Adjuvant ChemoTherapy after SBRT of Early-Stage Non-Small Cell Lung Cancer? Radiotherapy and Oncology. 120: S59. DOI: 10.1016/S0167-8140(16)33560-5  0.599
2016 Jumeau R, Filion E, Bahig H, Vu T, Lambert L, Roberge D, Doucet R, Campeau M. 160: Limiting Chest Wall Toxicity by Adapting the Dose Schedule and Dose Constraints in SBRT for Early-Stage Lung Cancer Radiotherapy and Oncology. 120: S59. DOI: 10.1016/S0167-8140(16)33559-9  0.593
2016 Mathieu D, Campeau M, Doucet R, Zerouali K, Bedwani S, Bahig H, Lambert L, Thuc Vu TT, Roberge D, Filion É. 151: Does MID-Treatment CBCT-Guided Patient Repositioning During Lung VMAT Impact Target Coverage? Radiotherapy and Oncology. 120: S56. DOI: 10.1016/S0167-8140(16)33550-2  0.595
2016 Bahig H, Vu T, Nguyen NT, de Guise J, Lebeau M, Chartrand-Lefebvre C, Blais D, Bedwani S, Roberge D. 73: Preliminary Results from a Pilot Study on the Role of Dual Source Computed Tomography for Cardiac Sparing in Left Breast Radiotherapy Radiotherapy and Oncology. 120: S28-S29. DOI: 10.1016/S0167-8140(16)33472-7  0.648
2016 Bahig H, Campeau M, Roberge D, Lapointe A, Stephane B, Vu T, Lambert L, de Guise J, Blais D, Chartrand-Lefebvre C, Lord M, Del Vecchio P, Filion E. 43: Phase I-II on the use of Dual-Energy Computed Tomography (DECT) for Assessment of Differential Pulmonary Function in Radiotherapy Planning Radiotherapy and Oncology. 120: S17. DOI: 10.1016/S0167-8140(16)33442-9  0.664
2016 Bahig H, Nguyen-Tan FP, Filion E, Roberge D, Thanomsack P, Doucet R, Blais D, Lambert L. 3: Laryngeal Motion Dynamics using 4D-Computed Tomography and Dynamic Magnetic Resonance Imaging Radiotherapy and Oncology. 120: S1-S2. DOI: 10.1016/S0167-8140(16)33402-8  0.532
2016 Lapointe A, Besnier M, Blais D, Bahig H, De Guise J, Carrier J, Filion E, Roberge D, Bedwani S. OC-0417: Functional imaging using dual energy Computed Tomography and its application in radiation oncology Radiotherapy and Oncology. 119: S194-S195. DOI: 10.1016/S0167-8140(16)31666-8  0.537
2016 Iskanderani OF, Dominic BN, Doucet R, Coulombe G, Pascale D, Roberge D. Reproducibility of a Noninvasive System for Ocular Immobilization in Robotic Stereotactic Radiation Therapy of Ocular Melanoma International Journal of Radiation Oncology Biology Physics. 96. DOI: 10.1016/J.Ijrobp.2016.06.2171  0.313
2016 Bahig H, Nguyen-Tan P, Filion E, Blais D, Roberge D, de Guise J, Lambert L. Assessment of Laryngeal Motion Dynamics Using 4D-Computed Tomography and Dynamic Magnetic Resonance Imaging International Journal of Radiation Oncology*Biology*Physics. 94: 919-920. DOI: 10.1016/J.Ijrobp.2015.12.163  0.637
2015 Toltz A, Shin N, Mitrou E, Laude C, Freeman CR, Seuntjens J, Parker W, Roberge D. Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 16: 5386. PMID 26699298 DOI: 10.1120/Jacmp.V16I5.5386  0.38
2015 Darsaut TE, Magro E, Gentric JC, Batista AL, Chaalala C, Roberge D, Bojanowski MW, Weill A, Roy D, Raymond J. Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial. Trials. 16: 497. PMID 26530856 DOI: 10.1186/S13063-015-1019-0  0.324
2015 Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RL, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. International Journal of Radiation Oncology, Biology, Physics. 92: 1053-9. PMID 26194680 DOI: 10.1016/J.Ijrobp.2015.04.039  0.322
2015 Roberge D, Leclerc-Champagne C, Doucet R, Seuntjens J. How Low Should You Go: Choice of Minimum Dose Prescription in Cranial Radiosurgery. CurēUs. 7: e282. PMID 26180706 DOI: 10.7759/Cureus.282  0.317
2015 Baldini EH, Wang D, Haas RL, Catton CN, Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C, Guadagnolo BA, O'Sullivan B, Petersen IA, Le Pechoux C, Abrams RA, DeLaney TF. Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. International Journal of Radiation Oncology, Biology, Physics. 92: 602-612. PMID 26068493 DOI: 10.1016/J.Ijrobp.2015.02.013  0.363
2015 Mathieu D, Campeau MP, Bahig H, Larrivée S, Vu T, Lambert L, Lavoie C, Roberge D, Doucet R, Carrier JF, Gorgos A, Fortin B, Filion E. Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy. Practical Radiation Oncology. 5: e365-73. PMID 25680997 DOI: 10.1016/J.Prro.2014.12.002  0.622
2015 Nguyen NT, Charron G, Blais D, Roberge D. Turn down the noise-a blinded evaluation of iterative image reconstruction in radiation therapy computed tomography simulation. Practical Radiation Oncology. 5: e393-400. PMID 25666989 DOI: 10.1016/J.Prro.2014.12.006  0.312
2015 Bahary P, Roberge D, Lambert C, Masucci L, Bahary J. Bmet-02Evaluation Of Different Therapeutic Modalities For Primary Treatment And Salvage Therapy And Their Relative Cost In Patients With Brain Metastases: A Single Institution Report. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov208.02  0.328
2015 Bahig H, Filion E, Vu T, Lambert L, Chalaoui J, Roberge D, Mathieu D, Beliveau-Nadeau D, Gagnon M, Campeau M. Severe Radiation Pneumonitis After Lung Stereotactic Ablative Radiation Therapy in Patients With Pulmonary Fibrosis International Journal of Radiation Oncology*Biology*Physics. 93: S152. DOI: 10.1016/J.Ijrobp.2015.07.361  0.627
2015 Bahig H, Filion E, Vu T, Lambert L, Mathieu D, Roberge D, Bouchard M, Lavoie C, Beliveau-Nadeau D, Prenovault J, Campeau M. Clinical Outcomes of a Patient Adapted Treatment Technique Selection Algorithm in Lung SABR International Journal of Radiation Oncology*Biology*Physics. 93: E443-E444. DOI: 10.1016/J.Ijrobp.2015.07.1677  0.568
2015 Rodrigues G, Yartsev V, Roberge D, MacRae RM, Roa W, Panet-Raymond V, Masucci L, Yaremko B, D'Souza DP, Palma DA, Sexton T, Yu E, Pantarotto JR, Ahmad B, Fisher B, et al. A Phase 2 Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-field Boost Radiation Therapy for Brain Oligometastases International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.095  0.336
2015 Sperduto P, Yang T, Beal K, Pan H, Brown P, Ho Y, Yeh N, Gaspar L, Braunstein S, Sneed P, Boyle J, Kirkpatrick J, Mak K, Shih H, Engelman A, ... Roberge D, et al. The Effect of Gene Mutations on Survival in Patients With Adenocarcinoma of the Lung Following the Development of Brain Metastases International Journal of Radiation Oncology*Biology*Physics. 93: S37-S38. DOI: 10.1016/J.Ijrobp.2015.07.092  0.333
2014 Mathieu D, Martel C, Campeau MP, Filion É, Roberge D, Bahig H, Vu T, Lambert L, Boudam K, Carrier JF. Accuracy of Breath-hold CT in Treatment Planning for Lung Stereotactic Ablative Radiotherapy. Cureus. 6: e236. PMID 28003937 DOI: 10.7759/Cureus.236  0.599
2014 Bahig H, Filion E, Vu T, Roberge D, Lambert L, Bouchard M, Lavoie C, Doucet R, Nadeau D, Chalaoui J, Campeau MP. Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis. Technology in Cancer Research & Treatment. PMID 24988054 DOI: 10.7785/Tcrt.2012.500445  0.625
2014 El-Bared N, Taussky D, Mehiri S, Patocskai E, Roberge D, Donath D. Preoperative intensity modulated radiation therapy for retroperitoneal sarcoma. Technology in Cancer Research & Treatment. 13: 211-6. PMID 23919397 DOI: 10.7785/Tcrt.2012.500371  0.398
2014 Bahig H, Simard D, L'tourneau L, Roberge D, Donath D, Wong P, Filion E, Beliveau-Nadeau D, Doucet R, Nicholson P, Masucci L. Quantitative MRI changes post-stereotactic ablative radiotherapy of the spine Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 41: S16-S17. DOI: 10.1017/Cjn.2014.88  0.552
2014 Bahig H, Simard D, Letourneau-Guillon L, Roberge D, Donath D, Wong P, Filion E, Beliveau-Nadeau D, Doucet R, Nicholson P, Masucci L. Quantitative MRI Changes Post–Stereotactic Ablative Radiation Therapy of the Spine International Journal of Radiation Oncology*Biology*Physics. 90: S911-S912. DOI: 10.1016/J.Ijrobp.2014.05.2588  0.592
2014 Nguyen N, Charron G, Roberge D. Blinded Evaluation of Sinogram Affirmed Iterative Reconstruction in Radiation Therapy Planning Images International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2355  0.332
2013 Toltz A, Shin N, Laude C, Roberge D, Freeman C, Seuntjens J, Parker W. SU-E-T-282: Prediction of Secondary Cancer in Pediatric, Adolescent, and Young Adult Patients Receiving Abdominal External Beam Radiotherapy. Medical Physics. 40: 269. PMID 28518547 DOI: 10.1118/1.4814716  0.363
2013 Vakilian S, Freeman C, Al-Suhaibani A, Roberge D. Kinetics of myxoid liposarcoma radiation response and effects on radiation dose delivery. Practical Radiation Oncology. 3: 180-5. PMID 24674362 DOI: 10.1016/J.Prro.2012.06.005  0.349
2013 Bahig H, Campeau MP, Vu T, Doucet R, Béliveau Nadeau D, Fortin B, Roberge D, Lambert L, Carrier JF, Filion E. Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience. International Journal of Radiation Oncology, Biology, Physics. 87: 583-9. PMID 23953636 DOI: 10.1016/J.Ijrobp.2013.06.2048  0.628
2013 Bahig H, Roberge D, Bosch W, Levin W, Petersen I, Haddock M, Freeman C, Delaney TF, Abrams RA, Indelicato DJ, Baldini EH, Hitchcock Y, Kirsch DG, Kozak KR, Wolfson A, et al. Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. International Journal of Radiation Oncology, Biology, Physics. 86: 298-303. PMID 23474110 DOI: 10.1016/J.Ijrobp.2013.01.032  0.611
2013 Sperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, et al. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. Journal of Neuro-Oncology. 112: 467-72. PMID 23462853 DOI: 10.1007/S11060-013-1083-9  0.309
2013 Shin N, Toltz A, Laude C, Roberge D, Freeman C, Seuntjens J, Parker W. Risk of Radiation-Induced Late Effects for Pediatric Patients Receiving Craniospinal Irradiation Comparing 3D-CRT, IMRT, and IMPT International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1833  0.344
2013 Bahig H, Filion E, Vu T, Roberge D, Lambert L, Bouchard M, Lavoie C, Doucet R, Béliveau-Nadeau D, Campeau M. Tumoricidal Robotic Radiation: 96% 2-Year Disease-Specific Survival Following Robotic Radiosurgery Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 87: S12. DOI: 10.1016/J.Ijrobp.2013.06.038  0.599
2012 Toltz A, Shin N, Laude C, Roberge D, Freeman C, Seuntjens J, Parker W. Poster - Thur Eve - 73: Prediction of risks of cardiac mortality and secondary cancers after radiotherapy for Hodgkin's lymphoma, non-Hodgkin's lymphoma, and breast cancer. Medical Physics. 39: 4639. PMID 28516626 DOI: 10.1118/1.4740182  0.349
2012 Katz AW, Winter KA, Dawson LA, Schell MC, Kim JJ, Chen Y, Roberge D, Crane CH, Willett C. RTOG 0438: A phase I trial of highly conformal radiation therapy for patients with liver metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 257. PMID 27982992 DOI: 10.1200/Jco.2012.30.4_Suppl.257  0.357
2012 Roberge D, Vakilian S, Alabed YZ, Turcotte RE, Freeman CR, Hickeson M. FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma. Sarcoma. 2012: 960194. PMID 23251096 DOI: 10.1155/2012/960194  0.313
2012 Sahgal A, Roberge D, Schellenberg D, Purdie TG, Swaminath A, Pantarotto J, Filion E, Gabos Z, Butler J, Letourneau D, Masucci GL, Mulroy L, Bezjak A, Dawson LA, Parliament M. The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy Clinical Oncology. 24: 629-639. PMID 22633542 DOI: 10.1016/J.Clon.2012.04.006  0.356
2012 Hanna WC, Sudarshan M, Roberge D, David M, Waschke KA, Mayrand S, Alcindor T, Ferri LE. What is the optimal management of dysphagia in metastatic esophageal cancer Current Oncology. 19: 60-66. PMID 22514498 DOI: 10.3747/Co.19.892  0.339
2012 Goetz P, Ebinu JO, Roberge D, Zadeh G. Current standards in the management of cerebral metastases. International Journal of Surgical Oncology. 2012: 493426. PMID 22312540 DOI: 10.1155/2012/493426  0.301
2012 Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 419-25. PMID 22203767 DOI: 10.1200/Jco.2011.38.0527  0.3
2012 Roberge D, Parney I, Brown PD. Radiosurgery to the postoperative surgical cavity: who needs evidence? International Journal of Radiation Oncology, Biology, Physics. 83: 486-93. PMID 22099047 DOI: 10.1016/J.Ijrobp.2011.09.032  0.355
2012 Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, et al. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. International Journal of Radiation Oncology, Biology, Physics. 82: 2111-7. PMID 21497451 DOI: 10.1016/J.Ijrobp.2011.02.027  0.319
2012 Pocinho R, Roberge D. Stereotactic Body Radiation Therapy for Liver Metastases: Single Institution Experience Cureus. 4. DOI: 10.7759/Cureus.42  0.336
2012 Toltz A, Shin N, Laude C, Roberge D, Freeman C, Seuntjens J, Parker W. TH-C-213AB-06: Risk of Radiation-Induced Cardiotoxicity and Secondary Cancers in Hodgkin's Lymphoma Patients Medical Physics. 39: 3994-3994. DOI: 10.1118/1.4736295  0.363
2012 Roberge D, Panet-Raymond V, Petrecca K, Souhami L. “Tri-modality” Therapy for Large Brain Metastases International Journal of Radiation Oncology*Biology*Physics. 84: S291-S292. DOI: 10.1016/J.Ijrobp.2012.07.761  0.305
2012 Roberge D, Bosch W, Bahig H, Levin W, Petersen I, Haddock M, Freeman C, DeLaney T, Abrams R, Wang D. Interobserver Variation in Suspicious Edema Definition for Preoperative Radiation Therapy in Soft-tissue Sarcoma of the Extremity International Journal of Radiation Oncology*Biology*Physics. 84: S168-S169. DOI: 10.1016/J.Ijrobp.2012.07.437  0.585
2012 Sperduto PW, Shanley R, Kased N, Roberge D, Chao ST, Jensen AW, Shih HA, Kirkpatrick J, Gaspar LE, Mehta M. The Effect of Tumor Subtype on the Time From Primary Diagnosis to Development of Brain Metastases and Survival in Women With Breast Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.368  0.307
2012 Toltz A, Shin N, Laude C, Roberge D, Freeman C, Seuntjens J, Parker W. Prediction of Excess Risks of Radiation-induced Cardiac Mortality and Secondary Cancers After Radiation Therapy for Hodgkin Lymphoma International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.2012  0.359
2012 Brown P, Shook S, Laack N, Wefel J, Choucair A, Suh J, Roberge D, Kavadi V, Mehta M, Watkins-Bruner D. Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiation Therapy (WBRT): First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial International Journal of Radiation Oncology*Biology*Physics. 84: S1-S2. DOI: 10.1016/J.Ijrobp.2012.07.017  0.32
2011 Sperduto PW, Kased N, Roberge D, Shanley R, Chao ST, Bhatt AK, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE. The effect of tumor subtype on survival and the graded prognostic assessment (GPA) for patients with breast cancer and brain metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 238. PMID 27958084 DOI: 10.1200/Jco.2011.29.27_Suppl.238  0.32
2011 Friedmann D, Wunder JS, Ferguson P, O'Sullivan B, Roberge D, Catton C, Freeman C, Saran N, Turcotte RE. Incidence and Severity of Lymphoedema following Limb Salvage of Extremity Soft Tissue Sarcoma. Sarcoma. 2011: 289673. PMID 22190861 DOI: 10.1155/2011/289673  0.32
2011 Roberge D, Skamene T, Turcotte RE, Powell T, Saran N, Freeman C. Inter- and intra-observer variation in soft-tissue sarcoma target definition. Cancer Radiothã©Rapie : Journal De La Sociã©Tã© Franã§Aise De Radiothã©Rapie Oncologique. 15: 421-5. PMID 21741872 DOI: 10.1016/J.Canrad.2011.03.006  0.319
2011 Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Kirsch DG, Hitchcock YJ, Wolfson AH, DeLaney TF. RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. International Journal of Radiation Oncology, Biology, Physics. 81: e525-8. PMID 21676552 DOI: 10.1016/J.Ijrobp.2011.04.038  0.379
2011 Wang D, Bosch W, Kirsch DG, Al Lozi R, El Naqa I, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Hitchcock YJ, Wolfson AH, DeLaney TF. Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists. International Journal of Radiation Oncology, Biology, Physics. 81: e775-80. PMID 21277104 DOI: 10.1016/J.Ijrobp.2010.11.033  0.346
2011 Berlach DM, Beliveau-Nadeau D, Roberge D. Robotic Radiosurgery and the "Fingers of Death" Cureus. 3. DOI: 10.7759/Cureus.33  0.326
2011 Shin N, Laude C, Soisson E, ElNaqa I, Freeman C, Roberge D, Seuntjens J, Parker W. WE‐G‐BRA‐09: Risk of Radiation‐Induced Secondary Cancers in Paediatric Patients: A Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiotherapy Medical Physics. 38: 3828-3828. DOI: 10.1118/1.3613414  0.351
2011 Twork G, Patrocinio H, Ruo R, Soisson E, Roberge D. SU‐E‐J‐149: Validation of the Spatial Accuracy of the ExacTrac Adaptive Gating System Medical Physics. 38: 3477-3477. DOI: 10.1118/1.3611917  0.301
2011 Vakilian S, Freeman C, Al-Suhaibani A, Roberge D. Myxoid Liposarcoma Radiation Response International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.952  0.308
2011 Shin N, Laude C, Soisson E, Roberge D, Freeman C, El Naqa I, Seuntjens J, Parker W. Risk of Radiation-Induced Secondary Cancers in Pediatric Patients with CNS Tumors: A Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 81: S877-S878. DOI: 10.1016/J.Ijrobp.2011.06.1567  0.376
2010 Roberge D, Hickeson M, Charest M, Turcotte RE. Initial McGill experience with fluorodeoxyglucose pet/ct staging of soft-tissue sarcoma. Current Oncology (Toronto, Ont.). 17: 18-22. PMID 21151405 DOI: 10.3747/Co.V17I6.538  0.33
2010 Roberge D, Souhami L. Tumor bed radiosurgery following resection of brain metastases: a review. Technology in Cancer Research & Treatment. 9: 597-602. PMID 21070082 DOI: 10.1177/153303461000900608  0.369
2010 Bernad DM, Sperduto PW, Souhami L, Jensen AW, Roberge D. Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers. Journal of Neuro-Oncology. 98: 249-52. PMID 20376550 DOI: 10.1007/S11060-010-0175-Z  0.341
2010 Parker W, Brodeur M, Roberge D, Freeman C. Standard and nonstandard craniospinal radiotherapy using helical TomoTherapy. International Journal of Radiation Oncology, Biology, Physics. 77: 926-31. PMID 20231076 DOI: 10.1016/J.Ijrobp.2009.09.020  0.322
2010 Roberge D, Ménard C, Bauman G, Chan A, Mulroy L, Sahgal A, Malone S, McKenzie M, Schroeder G, Fortin MA, Ebacher A, Milosevic M. Radiosurgery scope of practice in Canada: a report of the Canadian association of radiation oncology (CARO) radiosurgery advisory committee. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 95: 122-8. PMID 20170974 DOI: 10.1016/J.Radonc.2010.01.003  0.339
2010 Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. International Journal of Radiation Oncology, Biology, Physics. 77: 655-61. PMID 19942357 DOI: 10.1016/J.Ijrobp.2009.08.025  0.316
2010 Wang D, Bosch W, kirsch D, Lozi R, Naqa I, Roberge D, Finkelstein S, Petersen I, Saito N, DeLaney T. Poster Viewing AbstractVariations in the Gross Target Volume and Clinical Target Volume Evaluated by RTOG Sarcoma Radiation Oncologists for Preoperative Radiotherapy of Primary Extremity Sarcoma International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.1442  0.328
2009 Karam I, Devic S, Hickeson M, Roberge D, Turcotte RE, Freeman CR. PET/CT for radiotherapy treatment planning in patients with soft tissue sarcomas. International Journal of Radiation Oncology, Biology, Physics. 75: 817-21. PMID 19386424 DOI: 10.1016/J.Ijrobp.2008.11.055  0.315
2009 Roberge D, Petrecca K, El Refae M, Souhami L. Whole-brain radiotherapy and tumor bed radiosurgery following resection of solitary brain metastases. Journal of Neuro-Oncology. 95: 95-9. PMID 19381439 DOI: 10.1007/S11060-009-9899-Z  0.4
2009 Huang F, Alrefae M, Langleben A, Roberge D. Prophylactic cranial irradiation in advanced breast cancer: a case for caution. International Journal of Radiation Oncology, Biology, Physics. 73: 752-8. PMID 18954943 DOI: 10.1016/J.Ijrobp.2008.05.031  0.345
2009 Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. International Journal of Radiation Oncology, Biology, Physics. 73: 473-8. PMID 18554821 DOI: 10.1016/J.Ijrobp.2008.04.030  0.358
2009 Alrefae MA, Roberge D, Souhami L. Short-course irradiation as adjuvant treatment of surgically resected single brain metastases Journal of Clinical Oncology. 27: 2067-2067. DOI: 10.1200/Jco.2009.27.15_Suppl.2067  0.337
2009 Roberge D, Hickeson M, Charest M, Turcotte RE. Utility of total body FDG PET/CT imaging in the initial staging of soft-tissue sarcoma Journal of Clinical Oncology. 27: 10531-10531. DOI: 10.1200/Jco.2009.27.15_Suppl.10531  0.339
2008 Elhateer HS, Muanza T, Roberge D, Ruo R, Eldebawy E, Lambert C, Patrocinio H, Shenouda G, Souhami L. Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas Current Oncology. 15: 286-292. PMID 19079630 DOI: 10.3747/Co.V15I6.293  0.353
2008 Ang C, Hauerstock D, Guiot MC, Kasymjanova G, Roberge D, Kavan P, Muanza T. Characteristics and outcomes of medulloblastoma in adults. Pediatric Blood & Cancer. 51: 603-7. PMID 18649371 DOI: 10.1002/Pbc.21588  0.329
2008 Huang F, Kavan P, Guiot MC, Markovic Y, Roberge D. When temozolomide alone fails: adding procarbazine in salvage therapy of glioma. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 35: 192-7. PMID 18574933 DOI: 10.1017/S0317167100008623  0.305
2008 Elhateer HS, Ruo R, Muanza T, Roberge D, Lambert C, Souhami L, Shenouda G. A Comparison of Helical Tomotherapy (HT), Fixed-field Intensity-modulated Radiotherapy (IMRT) and 3D Conformal Radiotherapy (3DCRT) Plans in Stereotactic Radiation Therapy of Skull Base Meningioma International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.711  0.338
2008 Wakil G, Vuong T, David M, Roberge D, Szego P, Devic S. Usefulness of endoscopically-placed radio-opaque clips in the localization of esophageal cancer for endoluminal brachytherapy and external beam radiation therapy Brachytherapy. 7: 161. DOI: 10.1016/J.Brachy.2008.02.212  0.346
2007 Parker W, Filion E, Roberge D, Freeman CR. Intensity-Modulated Radiotherapy for Craniospinal Irradiation: Target Volume Considerations, Dose Constraints, and Competing Risks International Journal of Radiation Oncology Biology Physics. 69: 251-257. PMID 17707279 DOI: 10.1016/J.Ijrobp.2007.04.052  0.315
2007 Roberge D, Muanza T, Blake G, Shustik C, Vuong T, Freeman CR. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides? British Journal of Dermatology. 156: 57-61. PMID 17199567 DOI: 10.1111/J.1365-2133.2006.07559.X  0.306
2006 Roberge D, Ruo R, Souhami L. Killing two birds with one stone: a dosimetric study of dual target radiosurgery using a single isocenter. Technology in Cancer Research & Treatment. 5: 613-7. PMID 17121438 DOI: 10.1177/153303460600500609  0.307
2006 Roberge D, Souhami L, Olivier A, Leblanc R, Podgorsak E. Hypofractionated stereotactic radiotherapy for low grade glioma at McGill University: long-term follow-up. Technology in Cancer Research & Treatment. 5: 1-8. PMID 16417396 DOI: 10.1177/153303460600500101  0.374
2005 Roberge D, Parker W, Niazi TM, Olivares M. Treating the contents and not the container: dosimetric study of hair-sparing whole brain intensity modulated radiation therapy. Technology in Cancer Research & Treatment. 4: 567-70. PMID 16173827 DOI: 10.1177/153303460500400510  0.368
2005 Roberge D, Nordstrom S, Corriveau C, Gosselin M, Olivares M, Shenouda G. Treatment of medium-sized juxtapapillary melanoma with external Co-60 photon therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 74: 71-3. PMID 15683673 DOI: 10.1016/J.Radonc.2004.10.003  0.307
2003 Roberge D, Gosselin M, Sultanem K, Corns R, Shenouda G. Safety of a simple asymmetric jaw technique in the treatment of head and neck cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 68: 149-52. PMID 12972309 DOI: 10.1016/S0167-8140(03)00188-9  0.321
2003 Roberge D, Souhami L. Stereotactic radiosurgery in the management of intracranial gliomas. Technology in Cancer Research & Treatment. 2: 117-25. PMID 12680792 DOI: 10.1177/153303460300200207  0.358
Show low-probability matches.